Barclays »

Sellas Life Sciences Group I shares owned by Barclays

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $294k 183k 1.61
2025-06-30 $378k 173k 2.19

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Sellas Life Sciences Group I

Vanguard Group
Frigate Ventures
BlackRock
Susquehanna International
Marshall Wace
Caligan Partners
Geode Capital Management
State Street Corporation
Morgan Stanley
Nuveen
Citadel Advisors
Northern Trust
GSA Capital Partners
Diadema Partners
Everhart Financial Group

View all funds holding Sellas Life Sciences Group I